The involvement of Bcl-2 in mast cell apoptosis

Novartis Foundation Symposium

Volumn 271, Issue , 2005, Pages 191-195

  Cohen Saidon, Cellina ^a   Razin, Ehud ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90; PROTEIN BCL 2;

APOPTOSIS; CELL CULTURE; CYTOLOGY; HUMAN; MAST CELL; METABOLISM; PHYSIOLOGY; REVIEW;

APOPTOSIS; CELLS, CULTURED; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MAST CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33745300487     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (26)

1. Adams JM, Cory S 2001 Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26:61-66
2. Asai K, Kitaura J, Kawakami Y et al 2001 Regulation of mast cell survival by IgE. Immunity 14:791-800
3. Belka C, Budach W 2002 Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology. Int J Radiat Biol 78:643-658
4. Blagosklonny MV, Fojo T 1999 Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer 83:151-156
5. Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM 1996 Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 56:1851-1854
6. Cervero C, Escribano L, San Miguel JF et al 1999 Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia. Am J Hematol 60:191-195
7. Cohen-Saidon C, Nechushtan H, Kahlon S et al 2003 A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival. Blood 102:2506-2512
8. Cory S, Huang DC, Adams JM 2003 The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22:8590-8607
9. Danial NN, Korsmeyer SJ 2004 Cell death: critical control points. Cell 116:205-219
10. de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM 2000 Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol 18:989-994
11. Dias S, Shmelkov SV, Lam G, Rafii S 2002 VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood 99:2532-2540
12. Ehrlich P 1877 Beitrage zur Kenntnis der Anilinfarbungen und ihrer Verwendung in der Mikroskopischen Technik. Arch Mikr Anat 13:263
13. Finotto S, Mekori YA, Metcalfe DD 1997 Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J Clin Invest 99:1721-1728
14. Fumo G, Akin C, Metcalfe DD, Neckers L 2004 17-Allylamino-17- demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells. Blood 103:1078-1084
15. Galli SJ 1990 New insights into 'the riddle of the mast cells': microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 62:5-33
16. Gross A, McDonnell JM, Korsmeyer SJ 1999 BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911
17. Hunt EA HT 1957 Mitotic activity of mast cells. Proc Soc Exp Biol Med. 94:166-169
18. Kambe M, Kambe N, Oskeritzian CA, Schechter N, Schwartz LB 2001 IL-6 attenuates apoptosis, while neither IL-6 nor IL-10 affect the numbers or protease phenotype of fetal liver-derived human mast cells. Clin Exp Allergy 31:1077-1085
19. Lin B, Kolluri SK, Lin F et al 2004 Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116:527-540
20. Mekori YA, Gilfillan AM, Akin C, Hartmann K, Metcalfe DD 2001 Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL. J Clin Immunol 21:171-174
21. Poommipanit PB, Chen B, Oltvai ZN 1999 Interleukin-3 induces the phosphorylation of a distinct fraction of bcl-2. J Biol Chem 274:1033-1039
22. Pratesi G, Perego P, Zunino F 2001 Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapy. Biochem Pharmacol 61:381-386
23. Razin E, Ihle JN, Seldin D et al 1984 Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol 132:1479-1486
24. Serafin WE, Austen KF 1987 Mediators of immediate hypersensitivity reactions. N Engl J Med 317:30-34
25. Xiang Z, Ahmed AA, Moller C et al 2001 Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation. J Exp Med 194:1561-1569
26. Yanagida M, Fukamachi H, Takei M et al 1997 Effect of a chymotrypsin-like inhibitor, TPCK, on histamine release from cultured human mast cells. J Pharm Pharmacol 49:537-541